Hoth Therapeutics Announces Its New Product, Ht-Alz Therapeutic, Gives Cognitive Improvements In Alzheimer’s Disease Model In Mouse
Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical, announced today proof-of-concept data recorded using cognitive and behavioral assessments in an Alzheimer’s disease mouse model (aged APP/PS1+/- mice), indicating that HT-ALZ has cognitive therapeutic potential after ... [Read]
Gb Sciences Ahead In Digital Transformation in Biopharma Industry Through Its Novel AI-Accelerated Drug Discovery Platform
Gb Sciences is a drug development and biopharmaceutical research company that began developing its proprietary digital research and analytics platform even before the pandemic prompted a digital change. According to a Deloitte report, biopharma lags ... [Read]
Flora Growth Announces Results of Annual Meeting of Shareholders; Appointment of Brandon Konigsberg to Board of Directors
FORT LAUDERDALE, Fla. & TORONTO — Flora Growth Corp. (NASDAQ:FLGC)(“Flora” or the “Company”), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, announced today that at the Company’s annual meeting of ... [Read]
Asep Medical Inc. Announces Appointment Of Dr. Robert E. W. Hancock As CEO And Chairman
VANCOUVER, BC, July 5, 2022 – Asep Medical Holdings Inc. (CSE:ASEP)(OTCQB:SEPSF) (“Asep Inc.” or the “Company”) has appointed Dr. Robert E. W. Hancock, the Co-Founder of Asep Inc, as the CEO and Chairman of the ... [Read]
Mountain Valley MD Holdings Completes Pre-clinical Pharmacokinetic Study for Soluvec
Mountain Valley MD Holdings (MVMD) (OTCQX: MVMDF) has announced the successful completion of its pre-clinical pharmacokinetic study. The pre-clinical pharmacokinetic study – IM032, was done on male beagle dogs by comparing the intramuscular (IM) and ... [Read]
Halberd Corporation Creates Subsidiary to Use Its Patented Technology to Treat Cancer (Halb)
Halberd Corporation (OTC PINK: HALB), after recognizing the depth of application of its recently patented extracorporeal treatment approach, has announced the creation of a new subsidiary. The subsidiary comprises a group of researchers focusing on ... [Read]
Flora Growth Congratulates Colombia’s Pro-Cannabis President-Elect
FORT LAUDERDALE, Fla. & TORONTO–Flora Growth Corp. (NASDAQ:FLGC) (“Flora” or the “Company”), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, congratulates Gustavo Petro and the Humane Colombia Party on their ... [Read]
Global Health Services Company, Cigna, Announces $3.5 Billion Accelerated Stock Repurchase Agreements
Cigna Corporation (NYSE: CI), a global health-service company, will repurchase $3.5 billion in common stock through accelerated stock repurchase agreements with two counterparties, Mizuho Markets Americas LLC and Morgan Stanley & Co. LLC (the “Counterparties”). ... [Read]
Flora Growth Corp. Announces $5 Million Share Repurchase Program
FORT LAUDERDALE, Fla. & TORONTO — Flora Growth Corp. (NASDAQ:FLGC) (the “Company” or “Flora”) a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, today announced that the Company’s Board of Directors ... [Read]
Biostage Inc Announces the Publication of Mechanical Strength Data for Regenerated Esophageal Tissue in Biomechanical Journal (BSTG)
A cell-therapy biotechnology company, Biostage Inc. (OTCQB: BSTG) (“Biostage” or the “Company”), has announced today the publication of a paper in the peer-reviewed Journal of Biomechanics. This published paper describes a study investigating the mechanical strength of ... [Read]